Clinical trial Recruiting at 1 site Observational Ages 10 to 59

Observational cohort of patients with spondyloarthritis at Nanfang Hospital

Official title: Bidirectional Cohort Study of Nanfang Spondyloarthritis

Run by Nanfang Hospital, Southern Medical University · NCT06988813 · Data updated 2026-11-12

This study is collecting health information from patients with spondyloarthritis at Nanfang Hospital to better understand the condition over time without changing their usual care.

More Ankylosing Spondylitis (AS) trials

Quick facts

Study typeObservational
Ages10 Years to 59 Years
SexAll
Enrollment3000 (estimated)
SponsorNanfang Hospital, Southern Medical University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedMay 17, 2025
Main results expectedApril 30, 2030
Study endsApril 30, 2030
Registry record updatedMay 25, 2025
Trial IDNCT06988813 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 10 to 59 years with a standardized diagnosis of spondyloarthritis who have attended Nanfang Hospital between 2010 and 2025.

Probably not a fit

Patients who are pregnant, preparing for pregnancy, breastfeeding, or have moderate to severe heart failure will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a specialized cohort of spondyloarthritis (SpA) patients at Nanfang Hospital, where clinical condition scales, laboratory indicators, and imaging data will be collected during routine follow-up visits. The cohort will archive disease characteristics, biochemical index data, and disease assessment scales without imposing any interventional treatments or additional tests on patients. Data will include disease duration, symptom characteristics, comorbidities, and various imaging results, creating a comprehensive dataset for future analysis of SpA. The study will span from 2010 to 2030, capturing both prospective and retrospective data.

Why it matters

Potential benefit: If successful, this study could enhance understanding of spondyloarthritis and improve patient management through comprehensive data collection.

How similar studies have gone: While this approach is observational and builds on existing methodologies, similar studies have shown success in establishing disease cohorts for chronic conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1.Attended Nanfang Hospital, Southern Medical University, 2010-2030 2.Prospective cohort study component: subjects voluntarily participate with informed consent and sign an informed consent form 3.Retrospective cohort study: (i) patients who visited the hospital from April 2010 to April 2024 (and who will not return to the hospital at a later date) were exempted from informed consent; (ii) patients who visited the hospital from May 2024 to April 2025 were required to sign an informed consent 4.10 years old ≤ age ≤ 59 years old 5.Patients with a standardized diagnosis of spondyloarthritis by the following guidelines or diagnostic criteria, i.e., meeting one of the following diagnostic criteria: (1) 2009 ASAS classification criteria for axial spondyloarthritis; (2) 2011 ASAS classification criteria for peripheral spondyloarthritis

Exclusion Criteria:

* 1\. Women who are pregnant, preparing for pregnancy or breastfeeding 2.Moderate to Severe Heart Failure (New York Heart Association Class 3-4) 3.Active peptic ulcers/bleeding 4.Judged by the investigator to be unsuitable for participation in this study

Where it's running

  • Nanfang Hostipal,Southern Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.